Formoterol Fumarate Solution
Product Images NDC 72603-620

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Formoterol Fumarate (NDC 72603-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (7c122969 483a 4c28 9aea 345c473929af 01)

FDA Label Image

Perforomist Figure 1 (7c122969 483a 4c28 9aea 345c473929af 02)

Mean FEV1 in Liters for Formoterol Fumarate Inhalation Solution 20 mcg (N=123) and Placebo (N=114) can be compared to evaluate the effectiveness of the medication in improving lung function.*

FDA Label Image

Perforomist Figure 2 (7c122969 483a 4c28 9aea 345c473929af 03)

Mean FEV1 in Liters for Formoterol Fumarate Inhalation Solution 20 mcg group (N=123) was 1.70, while for the Placebo group (N=114) it was not specified.*

FDA Label Image

Figure 1 (7c122969 483a 4c28 9aea 345c473929af 04)

FDA Label Image

Figure 2 (7c122969 483a 4c28 9aea 345c473929af 05)

FDA Label Image

Figures 3 And 4 (7c122969 483a 4c28 9aea 345c473929af 06)

FDA Label Image

1s Pouch (7c122969 483a 4c28 9aea 345c473929af 07)

FDA Label Image

20 Mcg/2 mL-30s Carton (7c122969 483a 4c28 9aea 345c473929af 08)

This text appears to be a product label for a Formoterol Fumarate Inhalation Solution in a 20 mcg/2 mL vial manufactured by 'NORTHSTAR'. It includes information such as the GTIN, expiration date, lot number, and NDC code (72603-620-30) for the product.*

FDA Label Image

4s Pouch (7c122969 483a 4c28 9aea 345c473929af 09)

FDA Label Image

20 Mcg/2 mL-60s Carton (7c122969 483a 4c28 9aea 345c473929af 10)

This is a detailed description of Formoterol Fumarate Inhalation Solution found in a sterile unit dose vial. The patient information enclosed discusses storage conditions before and after dispensing. The usual dosage is mentioned along with instructions for healthcare providers and patients on product expiration dates. The solution contains Formoterol fumarate, with inactive ingredients including citric acid, sodium citrate, sodium chloride, and water for injection. The solution should be used before the expiration date and stored properly. The manufacturing and distribution information is provided as well.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.